Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
Ebastine and its active metabolite produce rapid and prolonged, highly selective antagonism of peripheral histamine H1 receptors. They have low penetration of the blood–brain barrier and little anticholinergic activity, consistent with relatively low sedation.
Indications / reported uses
Symptomatic treatment of allergic rhinitis, including seasonal and perennial allergic rhinitis
Urticaria and other histamine-mediated allergic symptoms, according to the specific product authorisation
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Ebastine PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ebastine Permitted Daily Exposure (PDE) report (the Ebastine PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ebastine Occupational Exposure Limit (OEL) report (the Ebastine OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.